High-dose Therapy for Breast Cancer

This publication has 31 references indexed in Scilit:

• High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer
  Cancer, 1994
• Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer
  European Journal Of Cancer, 1993
• Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial
  Cancer, 1993
• Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies?
  Breast Cancer Research and Treatment, 1989
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer
  Cancer, 1987
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.
  The Journal of Experimental Medicine, 1983
• General motors cancer research foundation awards. Charles F. Kettering Award. Stepwise progress in the treatment of disseminated cancers
  Cancer, 1983
• Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
  New England Journal of Medicine, 1979